The country’s fertility regulator reported that the technique has “broad support.”
Daily News Roundup
The country’s fertility regulator reported that the technique has “broad support.”
A presidential bioethics commission lays out the framework for testing the anthrax vaccine in children.
Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research
The US government has come out with new rules for life science research deemed risky.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Researchers uncover more evidence that reprogrammed stem cells are not attacked by the immune system, suggesting they may one day serve as effective therapies.
After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
More than 140 nations agree to a plan to limit global mercury emissions.
A new initiative in the mathematics research community is gearing up to do the work traditionally organized by a publisher.